Clinical trial

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

NCT05937854

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-04-01

PhasePHASE2

Study timeline

Study start (actual)2024-04-01Date precision: day

Registry last updated2026-05-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Pulmonary Hypertensionunresolved

Dyspneaunresolved

Interventions

TadalafilDRUG · verified · RxNorm: tadalafil

Sponsors & collaborators

VA Office of Research and Developmentlead sponsor

VA Boston Healthcare Systemcollaborator

Atlanta VA Medical Centercollaborator

VA Eastern Colorado Health Care Systemcollaborator

VA Nebraska Western Iowa Health Care Systemcollaborator

Mapped research locations

BostonMassachusetts, United States1 AuroraColorado, United States1 OmahaNebraska, United States1 ProvidenceRhode Island, United States1 DecaturGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05937854 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.